Cargando…

The prophylactic use of C1 esterase inhibitor in HAE patients undergoing invasive procedures

Detalles Bibliográficos
Autores principales:	Harrison, Rachel, Santucci, Stephanie, Gavigan, Geneviève, Karsh, Jacob, Yang, William H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304019/ http://dx.doi.org/10.1186/1710-1492-10-S2-A15

Ejemplares similares

The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study
por: Gavigan, Geneviève, et al.
Publicado: (2014)

Self-administration of intravenous C1 esterase inhibitor (Berinertâ) in patients with Hereditary Angioedema decreases number of days spent in an emergency room
por: Rizk, Caroline, et al.
Publicado: (2011)

The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
por: MacRae, Megan, et al.
Publicado: (2014)

Laryngeal edema is common in HAE and demands preventive measures
por: Rosario, Cristine Secco, et al.
Publicado: (2015)

Seminal fluid anaphylaxis
por: Deria, Mariam, et al.
Publicado: (2011)

Treatment of hereditary angioedema with recombinant human C1 Inhibitor in a real-life setting: the experience of the HAE Centre in Milan
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Use of Omalizumab to treat a nine-year old, with steroid-dependent, allergic asthma, adrenal insufficiency and vertebral compression fractures due to steroid induced severe osteoporosis
por: Ring, Alicia, et al.
Publicado: (2011)

The perioperative course of C1-esterase-inhibitor: evidence for an early deficiency
por: Cobas Meyer, M, et al.
Publicado: (1999)

Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
por: Santucci, Stephanie, et al.
Publicado: (2014)

Short-term prophylaxis (STP) with plasma derived human C1 inhibitor concentrate (pdhC1-INH) in two pregnant women with hereditary angioedema (HAE): an experience in Rio de Janeiro – Brazil
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

A case of acquired angioedema associated with Waldenstrom’s macroglobulinemia treated with rituximab
por: Rizk, Caroline, et al.
Publicado: (2014)

Clinical evaluation of an allergen Challenge Theatre(TM)
por: Karsh, Jacob, et al.
Publicado: (2014)

Technical evaluation of an allergen Challenge Theatre(TM)
por: Kelly, Suzanne, et al.
Publicado: (2014)

Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history
por: Aygören-Pürsün, E, et al.
Publicado: (2013)

Controlled prophylactic normothermia
por: Broessner, Gregor, et al.
Publicado: (2012)

Early presentation of clinical hereditary angioedema symptoms in an infant
por: Pham, Hoang, et al.
Publicado: (2014)

The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews
por: Jean-Baptiste, Milenka, et al.
Publicado: (2022)

Anti-Ige monoclonal antibody therapy for the treatment of patients with chronic rhinosinusitis: a multi-disciplinary practice review
por: Kilty, Shaun J, et al.
Publicado: (2014)

HAE therapies: past present and future
por: Zuraw, Bruce L
Publicado: (2010)

Male breast cancer in the prophylactics programme by the Ministry of Health of Poland
por: Barczyk, Artur
Publicado: (2012)

549 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (Hae) Undergoing Home Treatment—A Clinical Surveillance Program
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2012)

Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy
por: De Waele, JJ, et al.
Publicado: (2003)

EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014)

HAE international home therapy consensus document
por: Longhurst, Hilary J, et al.
Publicado: (2010)

HAE patient self-sampling for biomarker establishment
por: Förster, Toni M., et al.
Publicado: (2021)

Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2022)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Postintubation tracheal injuries in critically ill patients - proposal for an additional prophylactic approach
por: Vukcevic, Z
Publicado: (1997)

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
por: O’Quinn, John, et al.
Publicado: (2014)

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014)

Induction of endotoxin (ET) tolerance by atoxic endotoxin - a new prophylactic concept to the septic syndrome
por: Staubach, K, et al.
Publicado: (1997)

ORAL montelukast versus inhaled beclomethasone in the prophylactic treatment of post ACUTE viral bronchiolitis wheezing
por: Dos Santos, Luciana Zignago Moreira, et al.
Publicado: (2015)

EHMTI-0245. Some clinical characteristics and prophylactic treatment in patients with moh in an out-patient clinical sample
por: Jovanovic, M, et al.
Publicado: (2014)

EHMTI-0336. Metabolic diet therapy in the prophylactic treatment of migraine headache in adolescents by using ketogenic diet
por: Farkas, MK, et al.
Publicado: (2014)

EHMTI-0175. Analysis of migraine among Nepalese population: classification, triggering factors, prophylactic and abortive treatment
por: Ojha, R, et al.
Publicado: (2014)

Successful use of daily intravenous infusion of C1 esterase inhibitor concentrate in the treatment of a hereditary angioedema patient with ascites, hypovolemic shock, sepsis, renal and respiratory failure
por: Pham, Hoang, et al.
Publicado: (2014)

83 Hereditary Angioedema and Normal C1-Inhibitor (HAE TYPE III): A Novel Mutation in the Coagulation Factor 12 Gene
por: Bork, Konrad, et al.
Publicado: (2012)

Preliminary results with Habib’s procedure
por: Mastromarino, R, et al.
Publicado: (2011)

Recurrent fever: diagnostic procedure
por: Cortis, Elisabetta
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ivtb0g96f4oo2ag1snofdv64af